Medtronic (MDT) announced CE Mark approval in the European Union and the United Kingdom for BrainSense Adaptive deep brain stimulation and ...

The Lifelong Health multidisciplinary research theme (MDT) within the Faculty of Medicine and Dentistry became active at the beginning of 2022, and officially came to a close in July 2024. The theme ...

The MDT in Crisis and Resilience builds on highly successful trauma and critical care clinical sciences and bring together social health and social sciences. Our research in this area core aspects of ...

Investors continue to be optimistic about MDT due to its impressive Neuroscience portfolio. Yet, the dull macroeconomic scenario poses a concern to the company's margins.

(RTTNews) - Medtronic plc (MDT), Monday said it received CE Mark approval for its BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier in the European Union and the ...